Novo Nordisk chairman says CEO's contract unlikely to be extended

April 30, 2015 8:46 AM

10 0

COPENHAGEN, April 30 (Reuters) - Novo Nordisk's chairman does not expect to extend the contract with current Chief Executive Lars Rebien Sorensen, who will leave the world's top insulin maker by 2019.

The company's chief operating officer, a 26-year company veteran who had been expected to become the new CEO, quit on Thursday.

Also read: Amazon misses on earnings, stock down 5%

Read more

To category page